Astellas Pharma Inc: Prostatic Hyperplasia trials

The registry lists 13 Prostatic Hyperplasia studies with Astellas Pharma Inc as lead sponsor. 1 are open to participants now and 4 have results posted.

Phase 1 1Phase 2 2Phase 3 2Phase 4 7No phase 1(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• A Study to Track the Safety of Vesomni in Men in South Korea Treated in Routine Clinical Practice for the Urinary Symptoms of Benign Prostatic Hyperplasia (Enlarged Prostate)Not yet recruitingNCT07619105
• A Study to Evaluate the Efficacy, Safety, and Tolerability of Mirabegron in Men With OAB Symptoms While Taking Tamsulosin Hydrochloride for Lower Urinary Tract Symptoms (LUTS) Due to Benign Prostatic Hyperplasia (BPH)CompletedNCT02757768Phase 4Results posted
• A Phase 4 Study to Evaluate the Efficacy, Safety, and Tolerability of Mirabegron in Male Subjects With Overactive Bladder (OAB) Symptoms, While Taking the Alpha Blocker for Benign Prostatic Hypertrophy (BPH)CompletedNCT02656173Phase 4Results posted
• Long Term Study of Solifenacin Succinate and Tamsulosin Hydrochloride Oral Controlled Absorption System (OCAS) in Males With Lower Urinary Tract SymptomsCompletedNCT01021332Phase 3Results posted
• Study of Solifenacin Succinate and Tamsulosin Hydrochloride OCAS in Males With Lower Urinary Tract SymptomsCompletedNCT01018511Phase 3Results posted
• Study to Evaluate the Clinical Efficacy and Safety of Tamsulosin Alone or in Combination With Solifenacin for the Treatment in Men With Lower Urinary Tract Symptoms Including Overactive Bladder SymptomsCompletedNCT02715024Phase 4
• EC905 Pharmacokinetic Profile StudyCompletedNCT02634489Phase 1
• A Study to Evaluate the Tolerability and Efficacy of Tamsulosin 0.4mg OCAS Formulation in Patients Who Are Unsatisfied With the Treatment of Tamsulosin 0.2mg Conventional FormulationCompletedNCT02180789Phase 4
• A Study to Evaluate the Efficacy and Safety of ASP4901 in Patients With Benign Prostate HyperplasiaCompletedNCT02038868Phase 2
• Post Marketing Study to Evaluate the Efficacy and Safety of Solifenacin in Patients With OAB (Overactive Bladder) After TURP (Trans-urethral Resection of Prostate) or PVP (Photoselective Vaporization of Prostate)CompletedNCT01747577Phase 4
• Solifenacin as Add-on Therapy for Overactive Bladder Symptoms in Men Treated for Benign Prostatic HyperplasiaCompletedNCT00771394Phase 4
• A Study With Combination Treatment (Tamsulosin Hydrochloride and Solifenacin Succinate) in Male Patients With LUTS/BPHCompletedNCT00510406Phase 2
• A Phase 4 Study With Tamsulosin OCAS to Assess Nighttime Voiding.CompletedNCT00379067Phase 4